Merdeka Battery Materials Tbk. vs Merck Tbk. — how do they compare? Merdeka Battery Materials Tbk. trades at Rp525 (market cap 56.16T, 48.81M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merdeka Battery Materials Tbk. is far larger — about 33× Merck Tbk.'s market cap, and Merdeka Battery Materials Tbk. is more actively traded (48.81M versus 37.6K). Which is the better fit depends on your goals.
| MBMA | MERK | |
|---|---|---|
Market Cap | 56.16T | 1.7T |
Volume | 48.81M | 37.6K |
Lot | 488.12K | 376 |
Turnover | 25.53B | 144.47M |
Average Price | 523.13 | 3,842.23 |
Value | 25.53B | 144.47M |
Indicative Equilibrium Price | 525 | 3,840 |
Indicative Equilibrium Volume | 41.15K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merdeka Battery Materials Tbk (formerly PT Hamparan Logistik Nusantara) (the “Company”) was established based on Notarial Deed No. 66 of Darmawan Tjoa, S.H., S.E., Notary in Jakarta, dated 20 August 2019. The Company’s immediate parent entity is PT Merdeka Energi Nusantara (formerlyPT Batutua Tambang Abadi) (“MEN”) and its ultimate parent entity is PT Merdeka Copper Gold Tbk (“MDKA”), a company incorporated in Indonesia and listed on the Indonesian Stock Exchange (“IDX”).
Read more on MBMA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →